DYNLT3, a member of the dynein light chain family, plays a crucial role in the cytoplasmic dynein motor protein complex, involved in intracellular transport and various cellular processes. As a homodimer, DYNLT3 contributes to the binding of dynein to specific cargos, including the spindle checkpoint protein BUB3. Additionally, it functions independently as a transcriptional modulator, impacting gene expression.
The inhibition of DYNLT3 can be achieved through various indirect mechanisms, as highlighted by the diverse set of chemicals presented. These inhibitors target different cellular pathways and processes, affecting DYNLT3 expression and function. For instance, compounds like resveratrol and Wortmannin indirectly impact DYNLT3 through the modulation of the PI3K/AKT pathway, crucial for cell survival and proliferation. Other inhibitors, such as brefeldin A and Latrunculin A, disrupt vesicular transport and actin cytoskeleton dynamics, respectively, influencing the intracellular trafficking of DYNLT3. These diverse inhibitors offer a spectrum of strategies to investigate and manipulate DYNLT3 function, providing valuable insights into the intricate regulatory networks involving this dynein light chain. Further research is essential to unravel the precise molecular mechanisms underlying each inhibitor's impact on DYNLT3 and to elucidate discoveries in cellular processes and intracellular transport.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
DNA crosslinking agent and alkylating agent. Indirectly inhibits DYNLT3 by inducing DNA damage and cell cycle arrest. Cellular responses to Mitomycin C-induced stress may impact the expression or stability of DYNLT3, although the precise mechanism remains to be fully elucidated. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor affecting the PI3K/AKT pathway. Indirectly inhibits DYNLT3 by modulating a signaling pathway crucial for cell survival and proliferation. Altered PI3K/AKT signaling may influence DYNLT3 expression or function, providing a potential indirect mechanism of inhibition. | ||||||